Related Experiment Videos

Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2

F Shibasaki1, E Kondo, T Akagi

  • 1Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Nature
|April 17, 1997
PubMed

Insights

The anti-apoptotic protein Bcl-2 binds calcineurin, preventing the transcription factor NF-AT from entering the nucleus. This interaction inhibits cell death signaling pathways, offering new therapeutic targets for cell death regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • The anti-apoptotic protein Bcl-2's mechanism for inhibiting cell death, particularly from calcium signaling and growth factor withdrawal, remains unclear.
  • Understanding Bcl-2's role is crucial for developing strategies to control cell death in various physiological and pathological conditions.

Purpose of the Study:

  • To elucidate the molecular mechanism by which Bcl-2 inhibits cell death.
  • To investigate the interaction between Bcl-2 and calcineurin in the context of cell death signaling.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Analysis of calcineurin phosphatase activity.
  • Assessment of NF-AT nuclear translocation using reporter assays.

Main Results:

  • Bcl-2 forms a tight complex with calcineurin, localized to cytoplasmic membranes via Bcl-2's BH4 domain.
  • Calcineurin bound to Bcl-2 remains an active phosphatase but cannot induce NF-AT nuclear translocation, thus suppressing NF-AT activity.
  • The pro-apoptotic protein Bax disrupts the Bcl-2-calcineurin interaction.

Conclusions:

  • Bcl-2 inhibits cell death by sequestering active calcineurin, preventing NF-AT signaling.
  • This interaction highlights a novel mechanism of Bcl-2-mediated cell death suppression.
  • Calcineurin may play a role in Bcl-2-regulated cellular functions, offering potential therapeutic avenues.

Related Concept Videos